NASDAQ:ALRN - Aileron Therapeutics, Inc.
$1.84
 $-0.08
-4.17%
2:45PM EDT
2019-02-15
Aileron Therapeutics, Inc., incorporated on August 6, 2001, is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and metabolic diseases and inflammation. The Company is advancing its lead oncology program to deliver efficacy and safety in a spectrum of solid and hematological malignancies. Its lead product candidate, ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers. The Company is conducting an ongoing Phase I clinical trial of ALRN-6924 in adult patients with solid tumors or lymphomas expressing non-mutated or wild-type p53 that are refractory to or intolerant of standard therapy. ALRN-6924 may reactivate p53-mediated cell death by targeting both of the natural p53 suppressor proteins, Mouse double minute 2 homolog (MDM2) and MDMX. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ALRN     avg for
industry  
  avg for
sector  
42 stocks weight:  65. 78   0. 00   0. 00  
42 stocks rank:  2. 37 K 1. 86 K 1. 09 K
# analyst opinions:  3. 00   14. 92   14. 43  
mean recommendation:  1. 00   1. 91   1. 93  

quick ratio:  3. 93   5. 37   1. 81  
current ratio:  4. 23   5. 69   2. 19  

target price low:  1. 57   88. 97   117. 82  
target price avg:  1. 90   115. 19   141. 96  
target price high:  3. 18   143. 40   163. 16  
1-yr high:  9. 32   124. 30   142. 77  
last close:  1. 92   101. 85   127. 84  
50-day avg:  1. 33   98. 27   122. 46  
200-day avg:  3. 05   99. 72   122. 70  
1-yr low:  0. 71   78. 19   100. 16  
volume:  186. 39 K 2. 38 M 4. 64 M
50-day avg volume:  290. 98 K 3. 31 M 4. 94 M
200-day avg volume:  124. 22 K 3. 23 M 4. 28 M

1-day return:  -7. 25 % 0. 22 % 0. 48 %
this week return:  14. 97 % 1. 77 % 2. 01 %
12-wk return:  -2. 54 % 6. 56 % 3. 33 %
52-wk return:  -78. 06 % -2. 23 % 14. 35 %

enterprise value (EV):  -3. 32 M 55. 17 B 104. 51 B
market cap:  28. 58 M 49. 01 B 96. 46 B
EBITDA:  -30. 65 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  0. 11   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
debt/equity:  19. 20   258. 01   110. 73  
net income (common):  -31. 38 M 2. 37 B 3. 58 B

shares outstanding:  14. 75 M 607. 99 M 1. 22 B
shares:  6. 09 M 605. 53 M 1. 15 B
shares short:  31. 90 K 11. 62 M 12. 55 M
shares short prior month:  89. 41 K 11. 95 M 13. 44 M
short ratio:  0. 19   4. 82   3. 10  
short % of float:  0. 39 % 6. 19 % 2. 82 %
total cash/share:  1. 90   12. 02   11. 46  
total cash:  27. 95 M 7. 41 B 7. 37 B
free cash flow:  -17. 05 M 95. 99 M 2. 04 B
operating cash flow:  -27. 10 M 164. 74 M 3. 04 B

book value:  1. 77   14. 43   28. 26  
price/book:  1. 09   -1. 57   -2. 97  
gross profits:  -14. 24 M 8. 28 B 18. 09 B
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  30. 00 % --- ---
1-yr mean volatility:  -0. 28 % 0. 01 % 0. 06 %

1-yr EPS:  -2. 13   3. 03   4. 09  
forward EPS:  -2. 12   4. 33   6. 99  
P/E:  -0. 90   6. 11   26. 91  
forward P/E:  -0. 80   8. 38   10. 48  
PE/G:  0. 03   0. 37   5. 61  
growth:  -31. 17 % 683. 72 % 104. 79 %
earnings high:  -0. 42   1. 27   1. 66  
earnings avg:  -0. 51   1. 01   1. 53  
earnings low:  -0. 62   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -39. 70 % -3. 27 % 3. 81 %
return on equity:  -78. 40 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  1. 12   1. 21   0. 93  
sharpe (1yr):  -0. 58   0. 06   0. 98  

held % insiders:  52. 67 % 6. 46 % 3. 21 %
held % institutions:  16. 99 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : ALRN
.        + 0 =             0 :: INITIAL WEIGHT
.  + 778.861 =       778.861 :: inverse volume-to-price addition
.  + 141.356 =       920.217 :: spline projection addition
.  - 261.354 =       658.863 :: poor performance penalty
.    x 0.525 =       345.859 :: one-year gains+dividend factor
.    x 9.604 =      3321.605 :: 13 weeks' performance factor
.    x 1.492 =      4957.459 :: industry recommendation factor
.    x 2.934 =     14544.523 :: symbol recommendation factor
.    x 0.996 =     14486.781 :: return on assets factor
.    x 0.992 =     14373.202 :: return on equity factor
.    x 2.743 =     39424.887 :: current ratio factor
.    x 1.158 =     45653.744 :: quick ratio factor
.    x 2.073 =     94655.253 :: short ratio factor
.    x 2.011 =      190339.6 :: price-to-book factor
.    x 1.037 =    197293.193 :: debt-to-equity factor
.    x 5.684 =   1121414.444 :: EBITDA multiple factor
.    x 1.427 =   1600599.059 :: 5-day avg > 50-day avg
.    x 2.172 =   3475997.538 :: P/E weight
.    x 2.209 =    7678336.44 :: PE/G factor
.    x 1.565 =  12017277.613 :: beta factor
.     x 0.58 =   6975245.182 :: sharpe factor
.    x 0.957 =   6676159.091 :: target low factor
.    x 0.982 =   6555387.164 :: target mean factor
.    x 1.081 =    7087086.85 :: target high factor
.    x 1.066 =    7552090.51 :: industry 12-weeks return
.    x 0.822 =   6205780.908 :: "drift" penalty 3 days ago
.      x 1.0 =   6204939.924 :: overall "drift" factor
.      x 0.7 =   4343458.243 :: largest single-day jump factor
.    x 0.066 =    284630.291 :: low price factor
.      x 1.0 =    284649.396 :: factor hist industry gain for week 06
.   cubeRoot =        65.781 :: reduced for readability
.                     65.781 :: FINAL WEIGHT for NASDAQ:ALRN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org